Care To Live & Deep Capture in a Twitter Over Death of 60,000

 Michael Milken, 60,000 Deaths, and the Story of Dendreon (Chapter 5 of 15) 29 June 2009 by Mark Mitchell In the latest chapter of this drama, CNBC's Jim Cramer makes "a mistake" -- again! --...

Canadian Scientists Boost Cancer Immune Response

Scientists at the Campbell Family Institute for Breast Cancer Research in Toronto have combined a naturally occuring component of the immune system with a viral vaccine.  The result boosted the body's immunity...

Will Dendreon Break FDA and Wall Street Stranglehold on Cancer?

Tomorrow, April 28, 2009, at long last the day of reckoning for Immunotherapy is upon us. Dendreon will present its statistically significant Impact trial results on Provenge at the American Urological...

Prostate Cancer History Was Made Today!

A non toxic, non invasive Immunotherapy to strengthen the body’s ability to fight prostate cancer achieved its goal of being  supportive of the previous trials, as required by the FDA. Mitchell Gold,...

FDA Creates Human Ticking Time Bombs

  The Wick Family has 4 men with prostate cancer. Too late. Make that 3. Brad's Uncle died this week. If Provenge were approved 2 years ago, as it should have been, he might still be with us today. With...

There Oughta Be A Law

Just when you thought it was safe, once again our Government proves it is one big revolving bed. Once again "we the people" are just an annoyance to the power elite. Who cares what we think and need. They will do...

Binex and MaxCyte collaborate on cancer immunotherapy research

""Based upon its impressive capabilities, we believe MaxCyte's cell loading technology can be an important component of our closed system," said Baek Chun Lee, Ph.D., Binex's Chairman. "Our immunotherapy product is currently undergoing review by the Korean FDA for colorectal...

closeSign in to NowPublic

is reporting from